Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Reece

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
G-CSF Primed Autologous Marrow Harvest and Transplantation in Cytapheresis "Mobilization Failure" Patients: A Descriptive Analysis; Bone Marrow TransplantationG. L. Phillips, G. A. Hale, D. S. Howard, et al.
Biotechnology Therapeutics|January 1, 1994
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's diseaseH G Klingemann, K Wilkie-Boyd, A Rubin, et al.
Bone Marrow Transplantation|October 22, 2008
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unitM A Trinkaus, S E Lapinsky, M Crump, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Gas-chromatographic analysis of busulfan for therapeutic drug monitoringL Embree, R B Burns, J R Heggie, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
G-CSF Primed Autologous Marrow Harvest and Transplantation in Cytapheresis "Mobilization Failure" Patients: A Descriptive Analysis; Bone Marrow TransplantationG. L. Phillips, G. A. Hale, D. S. Howard, et al.
Biotechnology Therapeutics|January 1, 1994
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's diseaseH G Klingemann, K Wilkie-Boyd, A Rubin, et al.
Bone Marrow Transplantation|October 22, 2008
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unitM A Trinkaus, S E Lapinsky, M Crump, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Gas-chromatographic analysis of busulfan for therapeutic drug monitoringL Embree, R B Burns, J R Heggie, et al.
Pageof 8